Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP1-modulated chromatin remodeling is a new target for cancer treatment
Saptarshi Sinha, Sefinew Molla, Chanakya Nath Kundu
Medical Oncology (2021) Vol. 38, Iss. 10
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A new wave of innovations within the DNA damage response
Qi Li, Wenyuan Qian, Yang Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response
Ali Bakr, G Corte, Olivera Veselinov, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 10, pp. 5698-5719
Open Access | Times Cited: 14
PARP1 at the crossroad of cellular senescence and nucleolar processes
Kinga Kołacz, Agnieszka Robaszkiewicz
Ageing Research Reviews (2024) Vol. 94, pp. 102206-102206
Closed Access | Times Cited: 8
Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions
Irina V. Bure, М. В. Немцова
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7848-7848
Open Access | Times Cited: 13
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
Saptarshi Sinha, Subarno Paul, S. Acharya, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4
Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113338-113338
Closed Access | Times Cited: 18
Transcriptional regulation mechanism of PARP1 and its application in disease treatment
Lu Yu, Wenliang Fu, Weiwei Xing, et al.
Epigenetics & Chromatin (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Research Progress in DNA Damage Response (DDR)-Targeting Modulators: from Hits to Clinical Candidates
Binbin Cheng, Zongbao Ding, Yun Hong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117347-117347
Closed Access
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3521-3535
Closed Access | Times Cited: 15
Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors
Subarno Paul, Saptarshi Sinha, Chanakya Nath Kundu
Pharmacological Research (2022) Vol. 184, pp. 106425-106425
Closed Access | Times Cited: 15
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Subarno Paul, Subhajit Chatterjee, Saptarshi Sinha, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 999-1015
Closed Access | Times Cited: 9
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance
Julia O’Sullivan, Charu Kothari, Marie‐Christine Caron, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 20, pp. 11056-11079
Open Access | Times Cited: 9
Increased DNA damage in full-grown oocytes is correlated with diminished autophagy activation
Fei Sun, Nourhan Nashat Ali, Daniela Londoño-Vásquez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
Nirashaa Bound, Cassandra J. Vandenberg, Apriliana E. R. Kartikasari, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite
Huabin Hu, Carmen Serra, Wenjie Zhang, et al.
Cell chemical biology (2024) Vol. 31, Iss. 5, pp. 973-988.e4
Open Access | Times Cited: 1
Respiratory Virus-Induced PARP1 Alters DC Metabolism and Antiviral Immunity Inducing Pulmonary Immunopathology
Mohamed Mire, Srikanth Elesela, Susan Morris, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 910-910
Open Access | Times Cited: 1
Activity of DNA Repair Systems in the Cells of Long-Lived Rodents and Bats
A. A. Popov, I. O. Petruseva, Olga I. Lavrik
Biochemistry (Moscow) (2024) Vol. 89, Iss. 6, pp. 1014-1023
Open Access | Times Cited: 1
Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment
Bo Feng, Hui Yu, Xu Dong, et al.
Journal of Chemical Information and Modeling (2024)
Open Access | Times Cited: 1
PARP in colorectal cancer: Molecular mechanisms, immunity, clinical trials, and drug combinations
Fahong Wu, Hangzhi Wei, Hong-Yang Deng, et al.
Neoplasma (2022) Vol. 70, Iss. 01, pp. 1-14
Open Access | Times Cited: 7
Epigenetics and alternative splicing in cancer: old enemies, new perspectives
Madhura R. Pandkar, Sanjeev Shukla
Biochemical Journal (2024) Vol. 481, Iss. 21, pp. 1497-1518
Closed Access | Times Cited: 1
The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia
Xinxin Lu, Xinyue Huang, Haiqi Xu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Exploring the effect of capsaicin on gene expression and chemotherapy sensitization in gastric cancer cells
Weijian Meng, Sophia Xie, Rui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines
Hasan Hüseyin Kazan, İrem Sinem Acınan, B. Kandemir, et al.
Gene (2024) Vol. 937, pp. 149139-149139
Closed Access
Activity of DNA Repair Systems in Cells of Long-Lived Rodents and Bats (Review)
A. A. Popov, I. O. Petruseva, O. I. Lavrik
Биохимия (2024) Vol. 89, Iss. 6, pp. 996-1006
Closed Access
Near Infrared-Responsive Quinacrine–Gold Hybrid Nanoparticles Deregulate HSP-70/P300-Mediated H3K14 Acetylation in ER/PR+ Breast Cancer Stem Cells
Somya Ranjan Dash, Chinmay Das, Biswajit Das, et al.
Nanomedicine (2024) Vol. 19, Iss. 7, pp. 581-596
Closed Access
Page 1 - Next Page

Scroll to top